Bharat Parenterals Limited has submitted a regulatory filing to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Wednesday, August 05, 2026 at the company's registered office.
The primary agenda of the Board meeting is to consider, approve and take on record the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27).
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct, the Trading Window for dealing in securities of the company has been closed for all Designated persons and their immediate relatives. The trading window closure period began on Wednesday, July 01, 2026 and will remain in effect until forty-eight (48) hours after the declaration of the financial results.
The notice of this Board meeting is also available on the company's website at www.bplindia.in.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.